Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALLAD - Adjuvant Chemotherapy for Small Bowel Adenocarcinoma
2015-000729-35Phase 3Active
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Jun 2015
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of oxaliplatin in small bowel adenocarcinoma (SBA) (2 arms), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Disease-free survival. Started Jun 2015; status: active.
02
Drugs
oxaliplatin
03
Conditions
small bowel adenocarcinoma (SBA)
Beyond the preview
Go deeper on 2015-000729-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000729-35.